Health Condition 1: F411- Generalized anxiety disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed consent to participate in the study. Patients of Generalized anxiety disorder diagnosed as per DSM-5 should be on standard treatment from past six weeks to six months. Patient with GAD7 Anxiety score greater or equal to 10
Exclusion criteria
Exclusion criteria: Any medical comorbidity that can cause anxiety or requiring priority management. 2. Any contraindication to tDCS or rTMS. 3. Any other psychiatric comorbidity (except tobacco use disorder and other anxiety disorders- Panic disorder, Social Anxiety Disorder, Agoraphobia and other phobias)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the efficacy and safety of add on tDCS to standard treatment in Generalized anxiety disorder. 2.To evaluate the efficacy and safety of add on rTMS to standard treatment in Generalized anxiety disorder. Timepoint: The outcome will be assessed at baseline, 1 week, 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the efficacy and side effects of above both groupsTimepoint: at baseline, after 1 week, 2 weeks and 4 weeks | — |
Countries
India
Contacts
King Georges Medical University Lucknow